You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome

 

Online download statistics by month:

Online download statistics by month: June 2022 to August 2025

AbstractFullPdf
Jun 202221821843
Jul 2022916942271
Aug 2022498520123
Sep 2022396412143
Oct 2022357376119
Nov 2022337338106
Dec 202223423687
Jan 2023303316112
Feb 2023295302120
Mar 2023256257103
Apr 202320721098
May 2023225228108
Jun 202317117462
Jul 202321121674
Aug 202318819068
Sep 2023228234104
Oct 202319719798
Nov 202319319790
Dec 202317017293
Jan 2024147148104
Feb 202414814969
Mar 2024270275156
Apr 2024210215135
May 202418218298
Jun 2024203205110
Jul 2024188189105
Aug 202413813581
Sep 2024154154112
Oct 2024178178102
Nov 2024200204103
Dec 2024220232108
Jan 202515315494
Feb 2025140140112
Mar 2025153153123
Apr 2025188188127
May 202515315396
Jun 202511911979
Jul 2025110
Aug 2025110
Total874689103936